XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation (Details) Share Based Compensation (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended 9 Months Ended
Sep. 30, 2012
plan
Sep. 30, 2011
Sep. 30, 2012
plan
Sep. 30, 2011
Dec. 31, 2011
Sep. 30, 2012
RSU
Sep. 30, 2011
RSU
Sep. 30, 2012
RSU
director
Sep. 30, 2011
RSU
May 31, 2011
RSA
May 31, 2010
RSA
May 31, 2009
RSA
May 31, 2008
RSA
Sep. 30, 2012
RSA
Sep. 30, 2012
SAR
Dec. 31, 2011
SAR
Sep. 30, 2012
Common Stock
Sep. 30, 2012
Common Stock
RSU
Share-based Compensation                                    
Number of stock-based compensation plans in effect 1   1                              
Number of shares of issuable common shares 2,654,000   2,654,000                              
Stock-based compensation expense           $ 946,000 $ 1,100,000 $ 2,900,000 $ 3,300,000                  
Exercise of restricted stock units, shares                                 94,000 94,176
RSA issued to each non-employee director                   700 700 700 700          
RSUs issued to each non-employee director               2,286                    
Number of non-employee directors receiving grants               6                    
Summary of Activity of the RSU, RSA and SAR:                                    
Outstanding, beginning of period               594,000           5,046 1,812,079 1,812,079    
Granted               13,716                     
Vested               (140,000)           (5,046)        
Outstanding, end of period           467,716   467,716           0 1,812,079 1,812,079    
Unrecognized compensation cost           7,457,000   7,457,000           0        
Award vesting period               1 year   1 year 1 year 1 year 1 year          
Summary of SAR Activity, Other Data:                                    
Weighted average exercise price, outstanding                             $ 36.16 $ 36.16    
Outstanding, weighted average contractual term     4 years   4 years 6 months                          
Weighted average exercise price, outstanding                             $ 36.16 $ 36.16    
Outstanding, weighted average contractual term     4 years   4 years 6 months                          
Deferred Compensation:                                    
Deferred compensation payable 38,800,000   38,800,000   36,300,000                          
Increase in deferred compensation liability     2,500,000                              
Increase in fair value of plan assets     2,300,000                              
Deferred compensation expense $ 880,000 $ (918,000) $ 2,300,000 $ 1,300,000